Home > Insider Trading > Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc. (IOVA)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks

In this article, we will take a detailed look at Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks. For a quick overview of such stocks, read our article Billionaire Paul Tudor Jones and...

Keep Reading →

March 15th, 2024 - Hedge Funds Insider Trading News

5 Best Biotech Stocks To Buy Under $20

In this article, we are going to take a closer look at five best biotech stocks to buy under $20.

Keep Reading →

March 13th, 2024 - Hedge Funds News

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q4 2023 Earnings Call Transcript

Iovance Biotherapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.45 EPS, expectations were $-0.44. Iovance Biotherapeutics, Inc.

Keep Reading →

February 29th, 2024 - News Transcripts

5 Stocks With Heavy Insider Buying In 2024

Wayne Rothbaum is a board member at California-based Iovance Biotherapeutics, Inc (NASDAQ:IOVA).

Keep Reading →

February 29th, 2024 - Insider Trading News

5 Best Short Squeeze Stocks To Buy Now

In this piece, we will take a look at the five best short squeeze stocks to buy now.

Keep Reading →

February 22nd, 2024 - Hedge Funds

5 Most Promising Cancer Stocks According to Analysts

In this piece, we will take a look at the five most promising cancer stocks according to analysts.

Keep Reading →

December 18th, 2023 - News

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q3 2023 Earnings Call Transcript

Operator: Welcome to the Iovance Biotherapeutics Third Quarter and Year-to-Date 2023 Financial Results and Corporate Update Conference Call.

Keep Reading →

November 8th, 2023 - News Transcripts

Should You Exit Iovance Biotherapeutics (IOVA) Following the Recent Uncertainty?

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here.

Keep Reading →

October 24th, 2023 - Hedge Fund Investor Letters News

Hedge Fund and Insider Trading News: Cathie Wood, Steve Cohen, Ress Capital, Brevan Howard Asset Management, ExodusPoint Capital Management, CNX Resources Corp (CNX), Iovance Biotherapeutics, Inc. (IOVA), and More

Investors will flock to funds focusing on buzzy themes when the Federal Reserve cuts interest rates, according to Cathie Wood, who is doubling down on innovative investment strategies with a new acquisition...

Keep Reading →

September 20th, 2023 - Hedge Funds Insider Trading

Hedge Fund and Insider Trading News: Ray Dalio, John Paulson, Paul Singer, Point72 Asset Management, Bayberry Capital Partners, Iovance Biotherapeutics Inc (IOVA), ModivCare Inc. (MODV), and More

Billionaire John Paulson has banned his long-term business partner from his string of hotels in Puerto Rico - days after he launched a $50million lawsuit against him.

Keep Reading →

September 18th, 2023 - Hedge Funds Insider Trading